Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/22/2023* 16:30 EST Earnings Call Q4 2022 -- -- --
02/22/2023* -- Results Q4 2022 -- 0.15 --
11/03/2022 16:30 EST Earnings Call Q3 2022 -- -- --
11/03/2022 -- Results Q3 2022 0.01 0.01 -31.88%
08/04/2022 16:30 EST Earnings Call Q2 2022 -- -- --
08/04/2022 -- Results Q2 2022 0.01 -0.03 132.1%
05/03/2022 16:30 EST Earnings Call Q1 2022 -- -- --
05/03/2022 -- Results Q1 2022 -0.01 0.04 -128.4%
*Estimated Date/Time

Earnings

Next Report Date 02/22/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2022
Beat/Miss Upgrade
Return Since 38.83%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
URL https://www.penumbrainc.com
Investor Relations URL https://investors.penumbrainc.com
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 22, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
18.57%
47.49%
29.86%
34.43%
6.53%
64.18%
-26.61%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
27.80%
67.55%
77.28%
4.27%
-44.97%
-34.61%
-23.90%
-32.35%
1.16%
15.32%
24.40%
-5.14%
16.21%
10.85%
11.45%
7.31%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-56.50%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-84.33%
As of December 02, 2022.

Profile

Edit
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
URL https://www.penumbrainc.com
Investor Relations URL https://investors.penumbrainc.com
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 22, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TMFS 3.290M USD 4.82%
FSMEX 284.40M USD 4.29%
FSPHX 270.18M USD 3.37%
FACTX 159.47M USD 2.80%
SCSMX 109.53M USD 2.77%
HTEC 1.862M USD 1.84%
NMGCX 25.81M USD 1.71%
BOSS 104372.0 USD 1.37%
FMCEX 22.37M USD 1.27%
IHI 43.87M USD 0.71%
ISCG 1.754M USD 0.46%
ISCB 445414.0 USD 0.22%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PEN Tweets